Dorzolamide HCl 2 % Ophthalmic Solution
RxNorm 310015
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 310015 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dorzolamide HCl 2 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Dorzolamide 20 mg/ML Ophthalmic Solution
(Atom ID: 1419260)
PTPrescribable
Designated preferred name (PT):
Dorzolamide (as dorzolamide hydrochloride) 20 mg/mL eye solution
(Atom ID: 10297615)
SYPrescribable
Synonym (SY):
Dorzolamide 2 % Ophthalmic Solution
(Atom ID: 2982032)
SYPrescribable
Synonym (SY):
Dorzolamide 20 mg/ML (as dorzolamide HCl 22.3 mg/ML) Ophthalmic Solution
(Atom ID: 6830262)
PSNPrescribable
Prescribable Name (PSN):
Dorzolamide HCl 2 % Ophthalmic Solution
(Atom ID: 7250362)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 mg/1 mL conventional release eye solution (clinical drug)
(Atom ID: 10311763)
Patient Education
Dorzolamide Ophthalmic
Ophthalmic dorzolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Dorzolamide is in a class of medications called carbonic anhydrase inhibitors. It works by decreasing the pressure in the eye.
[Learn More]
* Please review the disclaimer below.